MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CBIO — Crescent Biopharma, Inc. Common Stock
NasdaqCrescent Biopharma, Inc. Common Stock
$14.32
+0.06(+0.42%)
- O
- 14.48
- H
- 14.55
- L
- 14.07
- V
- 276.35K
⏱️ End-of-day dataAs of Oct 2, 2026
CBIO — Latest News & Headlines
6 Stories$CBIO stock is down 14% today. Here's what we see in our data. - Quiver Quantitative
$CBIO stock is down 14% today. Here's what we see in our data. Quiver Quantitative
Two Crescent employees received rights to buy 31,200 shares at $14.24 each - stocktitan.net
Two Crescent employees received rights to buy 31,200 shares at $14.24 each stocktitan.net
The Nascent Crescent Biopharma Thesis: One Year Later And Things Are Steady (NASDAQ:CBIO) - Seeking Alpha
The Nascent Crescent Biopharma Thesis: One Year Later And Things Are Steady (NASDAQ:CBIO) Seeking Alpha
Crescent Biopharma Announces Grants of Inducement Awards - marketscreener.com
Crescent Biopharma Announces Grants of Inducement Awards marketscreener.com
GlycoMimetics, the company behind GlycoMimetics stock, changes ticker to CBIO - AD HOC NEWS
GlycoMimetics, the company behind GlycoMimetics stock, changes ticker to CBIO AD HOC NEWS
Agenus (AGEN) Stock Jumps 8.73% to $7.85, Pressing Toward Key Resistance - Stock Buy Zone - dars.gov.et
Agenus (AGEN) Stock Jumps 8.73% to $7.85, Pressing Toward Key Resistance - Stock Buy Zone dars.gov.et